跳至主要内容
临床试验/JPRN-UMIN000008058
JPRN-UMIN000008058已完成未知

Impact of Cytochrome P450 2C19*2 Polymorphism on Intra-Stent Thrombus After drug eluting stent Implantation Receiving Clopidogrel. - Impact of Cytochrome P450 2C19*2 Polymorphism on Intra-Stent Thrombus After drug eluting stent Implantation.

Kobe University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2012年5月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)The patient who has a plan to receive surgical procedure. 2)The patient who received anticoagulant agent, thrombolytic drug, antiplatelet drug other than aspirin or clopidogrel. 3)There is contraindication of aspirin or clopidogrel. 4)The patient who do not agree with this trial. 5)inappropriate patient.

研究者

发起方
Kobe University Graduate School of Medicine

相似试验